Strategic Leadership Ethical Practices and Organizational Performance of Pharmaceutical Companies in Kenya
African Journal of Business and Development Studies · 2024
DOI: 10.70641/ajbds.v1i1.57 ↗Kurz gefasst
Fachartikel in der Zeitschrift African Journal of Business and Development Studies, 2024. Verfasst von Evelyn Njoki Ngaruiya und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
This study sought to determine the extent to which strategic leadership ethical practices influence the organizational performance of pharmaceutical companies in Kenya. A positivism research philosophy and descriptive correlational research design guided the study. A stratified random sampling technique was used to select a sample size of 390 from the target population of 1,746 senior managers. Primary data was collected using a self-administered questionnaire and analysed using descriptive and inferential statistics. The inferential statistics used included Pearson correlation analysis, Chi-square test, one-way ANOVA, and ordinal logistic regression for hypothesis testing. The results of ordinary logistic regression (Nagelkerke Pseudo R-Square) showed that strategic leadership ethical practices explained a variation of 5.4% in organizational performance, R2 =.054. Additionally, the ordinal logistic parameter estimates established strategic leadership ethical practices predicted organizational performance, β = .247, p ≤ .05. The study concluded that strategic leadership ethical practices significantly influenced the organizational performance of pharmaceutical companies in Kenya. The study recommends that pharmaceutical companies prioritize the development of ethical leadership skills among their top executives and managers. This can be achieved through leadership training programs, mentorship, and fostering a culture of ethics and integrity. The management of pharmaceutical companies should review and update their code of conduct to align with ethical principles and best practices. The code should clearly outline expected behaviours, ethical standards, and consequences for non-compliance. The management of pharmaceutical companies implements reward systems that incentivize and recognize ethical behaviour.
Zitieren
APA
Ngaruiya, E. N., K’Aol, G., & Njenga, K. (2024). Strategic Leadership Ethical Practices and Organizational Performance of Pharmaceutical Companies in Kenya. African Journal of Business and Development Studies. https://doi.org/10.70641/ajbds.v1i1.57
Vancouver
Ngaruiya EN, K’Aol G, Njenga K. Strategic Leadership Ethical Practices and Organizational Performance of Pharmaceutical Companies in Kenya. African Journal of Business and Development Studies. 2024. doi:10.70641/ajbds.v1i1.57
BibTeX
@article{Ngaruiya2024,
author = {Ngaruiya, Evelyn Njoki and K’Aol, George and Njenga, Kefah},
title = {Strategic Leadership Ethical Practices and Organizational Performance of Pharmaceutical Companies in Kenya},
journal = {African Journal of Business and Development Studies},
year = {2024},
doi = {10.70641/ajbds.v1i1.57}
}
EUVIMED